{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Identified as a direct interactor in a yeast two-hybrid screen, SUMO1 co-localizes with ATXN3 in the nucleus, suggesting a role in post-translational modification.",
  "functions": [
    {
      "function": "Post-Translational Modification of ATXN3",
      "arrow": "activates",
      "cellular_process": "ATXN3 is a substrate for SUMOylation, a post-translational modification where a Small Ubiquitin-like Modifier (SUMO) protein is covalently attached. SUMO1 is identified as a protein that directly modifies ATXN3.",
      "effect_description": "The covalent attachment of SUMO1, primarily at lysine 166 (K166) of ATXN3, increases the stability of the ATXN3 protein. This modification does not significantly alter ATXN3's subcellular localization or its propensity to form aggregates. However, by increasing the half-life of polyQ-expanded mutant ATXN3, SUMOylation enhances its cellular toxicity and promotes apoptosis.",
      "biological_consequence": [
        "SUMO1 is covalently attached to ATXN3, primarily at lysine 166 → SUMOylated ATXN3 exhibits increased protein stability → For polyQ-expanded mutant ATXN3, this leads to higher protein accumulation → Increased accumulation of mutant ATXN3 enhances its cytotoxicity, leading to increased apoptosis."
      ],
      "specific_effects": [
        "ATXN3 is covalently modified by SUMO1.",
        "The major SUMO1 modification site on ATXN3 is lysine 166 (K166).",
        "SUMOylation at K166 increases the protein stability of ATXN3, particularly the polyQ-expanded form.",
        "Increased stability of mutant ATXN3 due to SUMOylation leads to increased cytotoxicity and apoptosis."
      ],
      "evidence": [
        {
          "paper_title": "SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity",
          "journal": "PLoS One",
          "year": 2013,
          "relevant_quote": "We have previously shown that ataxin-3 was a new target of SUMOylation in vitro and in vivo. Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation did not influence the subcellular localization, ubiquitination or aggregates formation of mutant-type ataxin-3, but partially increased its stability and the cell apoptosis.",
          "pmid": "23382880"
        }
      ],
      "pathway": {
        "name": "Protein SUMOylation",
        "canonical_name": "Protein Sumoylation",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "23382880"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "regulates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The interaction is a post-translational modification *of* ATXN3 *by* the SUMOylation machinery, with SUMO1 being the modifying protein. ATXN3 is the substrate, not the enzyme, in this context. The input correctly described this directionality.",
  "mechanism": "ATXN3 is a substrate for SUMOylation, a post-translational modification where a Small Ubiquitin-like Modifier (SUMO) protein is covalently attached. SUMO1 is identified as a protein that directly modifies ATXN3.",
  "effect": "The covalent attachment of SUMO1, primarily at lysine 166 (K166) of ATXN3, increases the stability of the ATXN3 protein. This modification does not significantly alter ATXN3's subcellular localization or its propensity to form aggregates. However, by increasing the half-life of polyQ-expanded mutant ATXN3, SUMOylation enhances its cellular toxicity and promotes apoptosis.",
  "summary": "ATXN3 interacts with SUMO1 to modulate post-translational modification of atxn3, ultimately affecting increased accumulation of mutant atxn3 enhances its cytotoxicity, leading to increased apoptosis.",
  "evidence": [
    {
      "paper_title": "SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity",
      "journal": "PLoS One",
      "year": 2013,
      "relevant_quote": "We have previously shown that ataxin-3 was a new target of SUMOylation in vitro and in vivo. Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation did not influence the subcellular localization, ubiquitination or aggregates formation of mutant-type ataxin-3, but partially increased its stability and the cell apoptosis."
    },
    {
      "paper_title": "Covalent modification of ataxin-3 by SUMO-1",
      "journal": "Acta Biochimica et Biophysica Sinica",
      "year": 2006,
      "relevant_quote": "Small ubiquitin-like modifier 1(SUMO-1) was identified as a novel ataxin-3-interacting protein. Subsequently, co-immunoprecipitation showed that both the wild-type ataxin-3 and the polyglutamine-expanded ataxin-3 were covalently modified by SUMO-1 in SH-SY5Y cell..."
    }
  ],
  "pathways": [
    {
      "name": "Protein SUMOylation",
      "canonical_name": "Protein Sumoylation",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--regulates-- SUMO1:",
  "protein_a": "SUMO1",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-07T22:39:21.494484Z",
  "last_updated": "2025-12-07T22:39:21.494484Z"
}